Lorazepam Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Lorazepam Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on May 3, 2018. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1985-30
Dosage Form
Injection
Presentation
Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)
Initial Posting
May 3, 2018

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.